Results 121 to 130 of about 706 (137)

Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli. [PDF]

J Antimicrob Chemother
Paganini JA, Schürch AC, Scharringa J, Bonten MJM, Willems RJL, Plantinga NL.   +5 more
europepmc   +1 more source

From clinics to sewers: leveraging environmental surveillance and whole genome sequencing to inform transmission of ESBL-Escherichia coli in Switzerland

Conforti S, du Plessis L, Bagutti C, Becker J, Brugger SD, Cusini A, Egli A, Gaia V, Greub G, Guler C, Huisman JS, Kocher C, Kouyos RD, Leuzinger K, Maffioli C, Neacsu M, Nolte O, Ramette A, Seiffert SN, Tschudin-Sutter S, Zumthor JP, Stadler T, Julian TR.   +22 more
europepmc   +1 more source

Genomic insights into the circulation of pandemic fluoroquinolone-resistant extra-intestinal pathogenic Escherichia coli ST1193 in Vietnam

Microbial Genomics, 2021
Extra-intestinal pathogenic Escherichia coli (ExPEC) ST1193, a globally emergent fluoroquinolone-resistant clone, has become an important cause of bloodstream infections (BSIs) associated with significant morbidity and mortality.
Quynh Nguyen, Stephen Baker, Guy E Thwaites   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Escherichia coli ST1193: Following in the Footsteps of E. coli ST131

Antimicrobial Agents and Chemotherapy, 2022
Escherichia coli ST1193 is an emerging global multidrug (MDR) high-risk clone and an important cause of community-onset urinary and bloodstream infections.
Johann D D Pitout, Gisele Peirano, Liang Chen   +2 more
exaly   +3 more sources

Population-based epidemiology of Escherichia coli ST1193 causing blood stream infections in a centralized Canadian region

European Journal of Clinical Microbiology and Infectious Diseases, 2021
Escherichia coli ST1193 is an emerging global clone associated with fluoroquinolone resistance. A population-based study described genomics, clinical factors, susceptibility patterns, and incidence rates of ST1193 (n = 69) causing incident blood stream infections in a centralized Canadian region 2016-18.
Gisele Peirano, Diego B Nóbrega, Rebekah Devinney   +2 more
exaly   +4 more sources

Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China

European Journal of Clinical Microbiology and Infectious Diseases, 2020
Sequence type 1193 (ST1193) constitutes an emerging fluoroquinolone-resistant Escherichia coli clone in several countries. However, reports of such isolates in neonatal invasive diseases are limited. Here, we assessed the antimicrobial resistance and molecular characteristics of E.
Yijun Ding, Kaihu Yao, Wei Gao
exaly   +3 more sources

First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany

Journal of Global Antimicrobial Resistance, 2019
Sequence type 1193 (ST1193) is a new emerging global clone of Escherichia coli. The main goal of this study was to determine the prevalence and molecular characteristics of ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing E.
Giuseppe Valenza, Christiane Holler, Christian Bogdan   +2 more
exaly   +3 more sources

Re: Pandemic Fluoroquinolone Resistant Escherichia coli Clone ST1193 Emerged via Simultaneous Homologous Recombinations in 11 Gene Loci

Journal of Urology, 2020
Anthony Atala
exaly   +3 more sources